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Background: The transmission of the malaria parasite Plasmodium falciparum from the human to the mosquito is
mediated by dormant sexual precursor cells, the gametocytes, which become activated in the mosquito midgut.
Because gametocytes are the only parasite stages able to establish an infection in the mosquito, they play a crucial role
in spreading the tropical disease. The human-to-mosquito transmission triggers important molecular changes in the
gametocytes, which initiate gametogenesis and prepare the parasite for life-cycle progression in the insect vector.
Results: To better understand gene regulations during the initial phase of malaria parasite transmission, we focused on
the transcriptome changes that occur within the first half hour of parasite development in the mosquito. Comparison
of mRNA levels of P. falciparum gametocytes before and 30 min following activation using suppression subtractive
hybridization (SSH) identified 126 genes, which changed in expression during gametogenesis. Among these, 17.5% had
putative functions in signaling, 14.3% were assigned to cell cycle and gene expression, 8.7% were linked to the
cytoskeleton or inner membrane complex, 7.9% were involved in proteostasis and 6.4% in metabolism, 12.7% were cell
surface-associated proteins, 11.9% were assigned to other functions, and 20.6% represented genes of unknown
function. For 40% of the identified genes there has as yet not been any protein evidence.
For a subset of 27 genes, transcript changes during gametogenesis were studied in detail by real-time RT-PCR. Of
these, 22 genes were expressed in gametocytes, and for 15 genes transcript expression in gametocytes was increased
compared to asexual blood stage parasites. Transcript levels of seven genes were particularly high in activated
gametocytes, pointing at functions downstream of gametocyte transmission to the mosquito. For selected genes, a
regulated expression during gametogenesis was confirmed on the protein level, using quantitative confocal
microscopy.
Conclusions: The obtained transcriptome data demonstrate the regulations of gene expression immediately following
malaria parasite transmission to the mosquito. Our findings support the identification of proteins important for sexual
reproduction and further development of the mosquito midgut stages and provide insights into the genetic basis of
the rapid adaption of Plasmodium to the insect vector.
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Up to date, the tropical disease malaria is one of the
most devastating infectious diseases in the world, caus-
ing 216 million new cases and approximately 655.000
casualties each year [1]. Disease treatment and control
measures are undermined by the spread of drug resis-
tance in malaria parasites, particularly in populations of
Plasmodium falciparum, the agent responsible for mala-
ria tropica (reviewed in [2]).
The transmission of malaria parasites from the
human to the mosquito is mediated by specialized
sexual precursor cells, the intraerythrocytic gameto-
cytes. Maturation of P. falciparum gametocytes from
stage I to stage V takes approximately 10 days, and
during this period the gametocytes maintain a stable
cell cycle arrest (reviewed in [3,4]). The mature game-
tocytes circulate in the human’s blood stream, but
remain dormant until they are taken up by a blood-
feeding mosquito.
When entering the mosquito midgut together with the
blood meal, the gametocytes become activated from the
dormant stage by external stimuli, i.e. a drop in tempera-
ture and the contact with the mosquito-derived molecule
xanthurenic acid (XA) (reviewed in [5,6]). Gametocyte
activation leads to rounding up of the cell, followed by
parasite egress from the enveloping erythrocyte, which in-
volves the rupture of two membranes, the parasitophorous
vacuole membrane (PVM) and the erythrocyte membrane
[7] (reviewed [8]). During gametogenesis the microgame-
tocyte replicates its genome three times in order to pro-
duce eight motile microgametes. Following the fusion of
micro- and macrogametes a zygote forms and develops
into an infective ookinete within the following 24 hours.
The motile ookinete possesses an apical complex which
enables it to traverse the midgut epithelium before settling
down and forming an oocyst between epithelium and
basal lamina (reviewed in [5]).
During gametocytogenesis, P. falciparum expresses a
new set of genes important for sexual development
[9-14]. Ingestion by the blood-feeding mosquito again
triggers molecular changes in the sexual stage parasites,
which help adjusting the gametocytes to the insect and
which on the one hand initiate sexual reproduction and
further development of the parasite in the vector, on the
other hand prepare the emerging gametes for the hostile
environment of the mosquito midgut. Noteworthy, the
midgut stages have to persevere outside a host cell for
more than one day. During this time period, the cells are
highly vulnerable to the aggressive factors of the gut,
which among others include bacteria as well as human
immune cells, antibodies and complement proteins
present in the blood meal, and this exposure results in
an approximate 1000-fold loss of parasite abundance
[15] (reviewed in [5,6]).Gametocyte maturation and gametogenesis are par-
ticularly accompanied by the coordinated expression of
numerous adhesive surface proteins, including the EGF
domain-containing proteins Pfs25 and Pfs28, the 6-cys
proteins Pfs230 and Pfs48/45, and the LCCL domain-
containing PfCCp proteins. It is noteworthy that the
majority of these proteins can be divided into two clas-
ses: One class of the adhesion proteins, including Pfs230,
Pfs48/45 and the six PfCCp proteins, is expressed within
the parasitophorous vacuole (PV) of the developing ga-
metocyte, and the majority of these proteins assemble to
multimeric protein complexes [16,17] (reviewed in [18]).
The adhesion proteins are subsequently present on the
gamete surface, but expression of these proteins usually
ceases during fertilization. The expression of the second
class of surface proteins starts following parasite trans-
mission to the mosquito, as was shown for Pfs25 and
Pfs28, and expression often persists until the ookinete has
formed (reviewed in [5]). One reason for this sudden
onset of protein expression following gametocyte activation
in the mosquito midgut is the translational repression of
messenger RNA (mRNA) encoding for some of these pro-
teins. This was inter alia shown in the rodent malaria para-
site P. berghei for the repression of Pbs25 and Pbs28 by the
RNA helicase DOZI (development of zygote inhibited) as
part of a ribonucleoprotein complex [19]. DOZI and its
subsequently identified interaction partner CITH (CAR-I
and fly trailer hitch) are considered repressors of maternally
supplied mRNA important for ookinete development [20].
While astonishing advances have been made in previous
years in unveiling the molecular basis of parasite trans-
mission from the mammalian host to the mosquito, the
currently available data are fragmented and major key
players for gametogenesis and adaptation have not yet
been identified. We thus aimed at investigating the
changes in transcript levels during gametocyte activation
in order to gain in-depth knowledge on the molecular
switch-over that takes place in the parasite during trans-
mission. We selected the suppression subtractive hybri-
dization (SSH) technique to experimentally screen for
genes differentially expressed during gametocyte activa-
tion, because this PCR-based method amplifies induced
genes while simultaneously suppressing house-keeping
genes, and is thus particularly suited to discover new or
unexpected genes [21]. Our data provide insights into the
regulated gene expression of malaria parasites during
transmission to the mosquito and enable the identification
of novel proteins with essential functions for the mosquito
midgut stages, which might be suitable targets for trans-
mission blocking interventions.
Results and discussion
To determine changes in the transcriptome of malaria
parasites during the initial phase of transmission to the
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mature non-activated gametocytes and from gameto-
cytes at 30 min after in vitro activation, which have com-
pleted gametogenesis [7]. A subtracted cDNA library
was constructed and the resulting cDNA was assigned
to the respective plasmodial genes.
We identified a total number of 126 genes, for which
expression levels changed in the gametocytes during
activation. The majority of genes can be assigned to six
major ontology groups (Figure 1, Table 1): 22 genes
(17.5%) have putative functions in signaling, 18 genes
(14.3%) are assigned to processes linked to cell cycle and
gene expression, 11 genes (8.7%) can be linked to the
cytoskeleton or the inner membrane complex (IMC), 10
genes (7.9%) have putative functions in protein traffick-
ing, stabilization and degradation (proteostasis), eight
genes (6.4%) are linked to general metabolic functions,
and 16 genes (12.7%) are proteins of the cell surface or
PVM. Furthermore, 15 genes (11.9%) can be assigned to
other functions, including protein synthesis and process-
ing. A total of 26 genes (20.6%) encode for proteins with
unknown function, eight of which have sequences for
transmembrane domains and five of which encode for a
signal peptide.
Roughly 60% (76/126) of the SSH genes have been
detected in the currently available P. falciparum game-
tocyte proteomes, while for 40% there is as yet no
protein evidence (Table 2) [9,12,13,22]. Almost identical
numbers apply to the 113 orthologs of the rodent
malaria parasite P. berghei; the 13 P. falciparum genes
without P. berghei orthologs include amongst others the
three etramp genes, pfs16 and resa.
The P. berghei orthologs of the identified P. falciparum
genes were compared with a global gametocyte transcrip-
tome analysis of P. berghei DOZI and CITH gene deletion
mutants; destabilized mRNAs of these mutants are candi-
dates for translational repression in non-activated gameto-
cytes [19,20]. A total of 11 genes (8.7%) were identified as
candidates regulated by DOZI and CITH (Table 3); eight
of those lack any gametocyte protein evidence. One of theFigure 1 Ontology groups of P. falciparum genes with changes
in transcript expression during gametocyte activation. The
changes in transcript abundance were determined by SSH between
the mRNA of mature non-activated gametocytes and gametocytes
at 30 min p.a. in vitro. A total number of 126 genes were identified
(the numbers of genes per group are indicated).destabilized genes was identified as a single peptide hit
while the remaining two destabilized genes had 19 and 74
peptide hits in total. A number of 16 additional genes
were destabilized in the combined DOZI and CITH
datasets indicating they could also be under translational
control (data not shown). The data comparison indicates
that the majority of genes identified via SSH, which
change in transcript expression levels during gametocyte
activation, are not translationally controlled in non-
activated gametocytes, while many such genes have been
identified to function in zygote to ookinete transformation
[23]. In conclusion, gene regulation appears to be import-
ant for the early events of gametocyte activation, i.e. for
gametogenesis and fertilization, while translational repres-
sion particularly plays a role for the expression of proteins
important for ookinete development.
We used real-time RT-PCR analyses to confirm the
transcript changes in gametocytes during activation for a
subset of the identified genes and to determine, if these
genes become up- or down-regulated in their expression
during gametocyte activation. Total RNA was isolated
from immature (stages III and IV) and mature (stage V)
gametocytes of P. falciparum strain NF54 and from
activated gametocytes at 30 min post-activation (p.a.).
Furthermore, we isolated RNA from mixed asexual
blood stages of the gametocyte-less P. falciparum strain
F12. Initially, the synthesized cDNA of each sample was
tested for its stage-specificity by diagnostic RT-PCR,
using primers for the asexual blood stage gene ama-1
[24,25] and for the gametocyte-specific gene pfccp2 [26].
The tests confirmed that no pfccp2 transcript was
present in the F12 sample, while no ama-1 expression
was detected in the purified gametocyte samples of
strain NF54 (Figure 2A, left). The absence of ama-1
signals in the gametocyte samples and the absence of
pfccp2 in the F12 asexual blood stage sample further
showed that these were devoid of any contamination by
genomic DNA (gDNA). An additional test for gDNA con-
tamination was performed by using primers specific for
the gene hdac1 (histone deacetylase 1; PF3D7_0925700).
In all parasite samples, i.e. in samples of F12 asexual blood
stages as well as in NF54 immature, mature and activated
gametocytes, hdac1 transcript was present (Figure 2A,
right), as shown by diagnostic RT-PCR. In sample prepa-
rations lacking reverse transcriptase, on the other hand,
no hdac1-specific PCR bands were detected.
We chose 27 genes from the SSH analysis for com-
parison of transcript abundance, with representatives from
all ontology groups. The gene pfs16 was selected as an
internal control, because it is known to be highly ex-
pressed in gametocytes throughout development, while it
is absent in the gametes [7,27,28]. Furthermore two sexual
stage-specific genes, actin II and pfs25, served as external
controls. Pfs25 is expressed in vesicular structures during
Table 1 Genes of the Plasmodium falciparum gametocyte transcriptome as identified by SSH (comparing mature
non-activated gametocytes and gametocytes at 30 min p.a.)
Plasmodb ID Protein Predicted features pred. MW
Signaling
PF3D7_0214600 serine/threonine protein kinase 204.3
PF3D7_1356800 serine/threonine protein kinase ARK3 475.7
PF3D7_0302100 serine/threonine protein kinase PfCLK-4/SRPK1 Phosphorylation of SR splicing factors 157.4
PF3D7_1230900 atypical protein kinase, RIO family 111.5
PF3D7_1238900 calcium/calmodulin-dependent protein kinase, PK2 58.9
PF3D7_0624000 hexokinase, HK 55.3
PF3D7_0515300 phosphatidylinositol 3-kinase, PI3K 255.9
PF3D7_1113100 protein tyrosine phosphatase, PRL 25.1
PF3D7_1403900 phosphatase 35.2
PF3D7_1464600 phosphatase SP 170.5
PF3D7_0210600 conserved Plasmodium protein SP, calcium-lipid-binding domain CaLB 53.7
PF3D7_1238100 calcyclin binding protein Calcyclin-binding domain 266.4
PF3D7_1442200 GTP binding protein 118.7
PF3D7_1358600 zinc finger protein Zinc-Finger domain 118.3
PF3D7_0927200 zinc finger protein Zinc-Finger domain 189.7
PF3D7_1004300 zinc finger, C3HC4 type 131.7
PF3D7_1433400 conserved Plasmodium membrane protein 7 TMs, PHD C4HC3 zinc-finger-like motifs 682.5
PF3D7_1463900 conserved Plasmodium membrane protein SP, 7 TMs, EF hand calcium-binding domain 127.1
PF3D7_1233600 asparagine and aspartate rich protein 1, AARP1 Zinc-finger domain, Ring/U-Box 146.3
PF3D7_0530200 triose phosphate transporter iTPT SP, 7 TMs 59.8
PF3D7_0303900 conserved Plasmodium protein SP, phosphatidyl-ethanolamine-binding
protein PEBP domain
23.2
PF3D7_0818200 14-3-3 protein Regulative protein, binds signaling enzymes
like kinases or TM receptors
30.2
Cell cycle and gene expression
PF3D7_1445900 DEAD/DEAH box ATP-dependent RNA helicase 60.0
PF3D7_1019000 eukaryotic translation initiation factor subunit eIF2A 280.8
PF3D7_1417200 NOT family protein Regulation of transcript 519.8
PF3D7_1103800 CCR4-NOT transcription complex subunit 1, NOT1 4 TMs 392.0
PF3D7_0622900 ApiAP2 protein Transcription factor 237.4
PF3D7_0420300 ApiAP2 protein Transcription factor 400.2
PF3D7_0615400 ribonuclease 323.2
PF3D7_0811300 CCR4-associated factor 1, CAF1 200.2
PF3D7_1034900 methionine-tRNA ligase 101.2
PF3D7_1469700 conserved Plasmodium protein Homology to the transcriptional mediator
subunit Med6
24.6
PF3D7_0513600 deoxyribodipyrimidine photolyase 129.2
PF3D7_1105500 centrin-4 (CEN4) 20.1
PF3D7_1018500 PHF5-like protein mRNA splicing factor RDS3 domain 12.5
PF3D7_0827800 SET domain protein SET3 Chromatin regulator, nuclear protein,
in male gametocytes
283.6
PF3D7_1115200 SET domain protein, SET7 Chromatin regulator 94.3
PF3D7_1360900 polyadenylate-binding protein RNA-binding domain 44.8
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Table 1 Genes of the Plasmodium falciparum gametocyte transcriptome as identified by SSH (comparing mature
non-activated gametocytes and gametocytes at 30 min p.a.) (Continued)
PF3D7_1011800 QF122 antigen KH domain type 1, RNA binding 131.6
PF3D7_1347500 DNA/RNA-binding protein Alba 4, ALBA4 42.2
Cytoskeleton, IMC, Motor complex
PF3D7_0422300 alpha-tubulin II Cytoskeletal element 49.7
PF3D7_1246200 actin I IMC component 41.2
PF3D7_0503400 actin-depolymerizing factor 1, ADF1 13.7
PF3D7_1020200 kinesin 99.1
PF3D7_0724900 kinesin-like protein 222.6
PF3D7_1246400 myosin A tail domain interacting protein, MTIP IMC component 23.5
PF3D7_1251200 coronin Actin-binding protein 69.0
PF3D7_0708000 cytoskeleton-associated protein Cap-Gly domain 103.6
PF3D7_0515700 glideosome-associated protein 40, GAP40 10 TMs, IMC component 51.8
PF3D7_0918000 glideosome-associated protein 50, GAP50 SP, 2 TMs, IMC component 44.6
PF3D7_1351700 Alveolin, ALV6 IMC component 151.2
Proteostasis (Protein trafficking, stabilization and degradation)
PF3D7_0807500 proteasome subunit alpha type 6 Component oft he proteasome core particle 29.5
PF3D7_1466300 proteasome subunit RPN2 Proteasome non-ATPase regulatory subunit 1 132.8
PF3D7_0815800 vacuolar sorting protein, VPS9 Ortholog of Saccharomyces cerevisae
vacuolar sorting protein 9
214.7
PF3D7_1136400 conserved Plasmodium protein TPR domain, mediates protein interactions
and multi-protein complexes
107.1
PF3D7_0215400 conserved Plasmodium protein WD40-domain protein, assembly and
stabilization of MPCs
110.8
PF3D7_0818900 heat shock protein 70, HSP70-1 73.9
PF3D7_0917900 heat shock protein 70, HSP70-2 72.4
PF3D7_0306200 activator of Hsp90 ATPase, AHA1 41.6
PF3D7_0708400 heat shock protein 90, HSP90 86.2
PF3D7_0102200 ring-infected erythrocyte surface antigen, RESA PHIST and DnaJ domains 126.5
Metabolism, general
mal_mito_2 cytochrome c oxidase subunit I, cox1 SP, 12 TMs, component of the respiratory
chain in mitochondria
53.0
PF3D7_1444800 fructose 1,6-biphosphate aldolase Glycolysis pathway 40.1
PF3D7_0806800 vacuolar proton translocating ATPase subunit A 6 TMs 123.0
PF3D7_0922200 S-adenosylmethionine synthetase, SAMS 44.8
PF3D7_0801900 conserved Plasmodium protein FAD/NADP-binding domain 552.0
PF3D7_0403200 conserved Plasmodium protein Possibly acetyl-CoA-synthetase 69.4
PF3D7_0511800 myo-inositol 1-phosphate synthase 69.1
PF3D7_0104400 4-hydroxy-3-methylbut-2-enyl diphosphate reductase,
LytB
1 TM, protein export domain, non-
mevalonate pathway
62.5
cell surface and PVM
PF3D7_1035300 glutamate-rich protein; GLURP SP, on parasite surface 141.1
PF3D7_1335300 reticulocyte binding protein 2, RH2b 1 TM, on parasite surface, involved in
erythrocyte binding
382.9
PF3D7_1228600 merozoite Surface Protein 9, MSP-9 SP, on merozoite surface, involved in
erythrocyte binding
86.6
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Table 1 Genes of the Plasmodium falciparum gametocyte transcriptome as identified by SSH (comparing mature
non-activated gametocytes and gametocytes at 30 min p.a.) (Continued)
PF3D7_1028700 merozoite TRAP-like protein, MTRAP SP, 1 TM, belongs to TRAP family, in
micronemes and on merozoite surface
58.1
PF3D7_0731500 erythrocyte binding antigen 175, EBA-175 SP, 1 TM, Duffy binding domain, on
merozoite surface
174.6
PF3D7_0102500 erythrocyte binding antigen-181, EBA-181 SP, 2 TMs, Duffy binding domain, on
merozoite surface
181.2
PF3D7_1035700 duffy binding-like merozoite surface protein, DBLMSP SP, Duffy binding domain, SPAM 80.3
PF3D7_0202500 early transcribed membrane protein 2, ETRAMP2 SP, 1 TM, integral PVM protein 11.5
PF3D7_0423700 early transcribed membrane protein 4, ETRAMP4 SP, 2TMs, integral PVM protein 10.2
PF3D7_1033200 early transcribed membrane protein 10.2, ETRAMP 10.2 SP, 2TMs, integral PVM protein 38.9
PF3D7_1103500 CPW-WPC family protein SP, adhesin, cysteine-rich CPW-WPC domain 67.3
PF3D7_0406200 Pfs16 SP, 2 TMs, integral PVM protein of
gametocytes
16.7
PF3D7_0930300 merozoite surface protein 1, MSP1 SP, GPI anchor, EGF domain, on merozoite
surface, part of MSP complex
195.7
PF3D7_1218800 conserved Plasmodium protein, PSOP17 SP, lectin domain, laminin G2 domain 39.6
PF3D7_0707300 rhoptry-associated membrane antigen, RAMA GPI anchor, involved in erythrocyte binding 103.6
PF3D7_1021900 10b antigen Ankyrin repeat region, PHAX RNA-binding
domain, interacts with surface proteins like
PfEMP1 (Y2H)
267.4
Others
PF3D7_1103100 60S ribosomal protein P1 13.0
PF3D7_1027800 60S ribosomal protein L3 44.2
PF3D7_1408600 40S ribosomal protein S8e 25.1
PF3D7_1358800 40S ribosomal protein S13 17.3
PF3D7_0206200 metabolite/drug transporter 11 TMs, Major facilitator superfamily 62.7
PF3D7_1207700 blood stage antigen 41–3 precursor SP 43.4
PF3D7_1457000 signal peptide peptidase, SPP 8 TMs 47.6
PF3D7_0320700 signal peptidase complex subunit 2, SPC2 2 TMs, SPC25 domain 21.0
PF3D7_0207700 serine repeat antigen 4, SERA-4 SP, papain family cysteine proteinase 108.7
PF3D7_1033800 plasmepsin VII SP, 1 TM, aspartyl protease 52.3
PF3D7_0930000 procollagen lysine 5-dioxygenase 2 TMs 66.8
PF3D7_0817600 conserved Plasmodium protein MAC/PF domain 112.2
PF3D7_0403800 conserved Plasmodium protein Alpha/beta-hydrolase 83.4
PF3D7_0709900 conserved Plasmodium membrane protein 4 TMs, alpha/beta-hydrolase 274.0
PF3D7_0311600 conserved Plasmodium protein, unknown function SP, 1 TM, ribophorin-I domain,putative
dolichyl-diphospho-oligosaccharide-protein
84.0
Unknown
PF3D7_0904200 conserved Plasmodium protein SP, 1 TM 34.0
PF3D7_1024800 conserved Plasmodium protein SP, 2 TMs 171.1
PF3D7_1239400 conserved Plasmodium protein SP 22.0
PF3D7_0730800.1 Plasmodium exported protein SP 32.1
PF3D7_1316700 conserved Plasmodium protein SP 73.4
PF3D7_0601900 conserved Plasmodium protein 1 TM 14.7
PF3D7_0704100 conserved Plasmodium membrane protein 6 TMs 425.3
PF3D7_1023000 conserved Plasmodium membrane protein 5 TMs 48.9
PF3D7_1439600 conserved Plasmodium protein 1 TM 22.6
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Table 1 Genes of the Plasmodium falciparum gametocyte transcriptome as identified by SSH (comparing mature
non-activated gametocytes and gametocytes at 30 min p.a.) (Continued)
PF3D7_1021700 conserved Plasmodium membrane protein 4 TMs 830.2
PF3D7_0417400 conserved Plasmodium protein 2 TMs, interacts with PF3D7_1021700 (Y2H) 822.4
PF3D7_1026600 conserved Plasmodium protein Interacts with RNA-associated proteins (Y2H) 196.5
PF3D7_1362600 conserved Plasmodium protein Interacts with splicing factor 3B subunit
2 (Y2H)
32.1
PF3D7_0202400 conserved Plasmodium protein Pfg27 domain 141.9
PF3D7_1124200 conserved Plasmodium protein UAS domain 49.3
PF3D7_1452400 conserved Plasmodium protein 107.5
PF3D7_1225600 conserved Plasmodium protein 93.1
PF3D7_1451200 conserved Plasmodium protein 176.2
PF3D7_1438800 conserved Plasmodium protein 84.0
PF3D7_1114600 conserved Plasmodium protein 39.6
PF3D7_1026100 conserved Plasmodium protein 23.9
PF3D7_1230100 conserved Plasmodium protein 61.5
PF3D7_1321000 conserved Plasmodium protein 80.6
PF3D7_0411000 conserved Plasmodium protein 179.7
PF3D7_1126700 conserved Plasmodium protein 110.1
PF3D7_0508900 conserved Plasmodium protein 370.2
IMC, inner membrane complex; PVM, parasitophorous vacuole membrane; SP, signal peptide; TM, transmembrane; Y2H, yeast-two-hybrid.
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macrogametes following activation. Pfs25 is subsequently
present on the parasite surface until the ookinete stage
[16,29-32]. Actin II is a sexual stage-specific actin isomer,
and in P. berghei actin II was reported to play a role
during microgametogenesis [33,34]. In addition, the gene
su α5, encoding for subunit (SU) α5 of the α-ring of the
proteasome core particle [35], was included in the
investigations.
Transcript expression levels were measured via real-
time RT-PCR and calculated by the 2-ΔCt method [36,37]
in which the threshold cycle number (Ct), was normalized
to the Ct of the endogenous control gene encoding for
P. falciparum seryl tRNA synthetase (PF3D7_0717700) as
reference gene [38,39]. Transcript levels with 2-ΔCt values
below 0.5 were considered negligible. Real-time RT-PCR
revealed transcription in mature gametocytes for 22 out of
the 27 genes. Out of these, 15 genes showed increased
transcript expression in gametocytes compared to asexual
blood stage parasites (Figure 2B).
Seven genes were identified, i.e. PF3D7_0827800 (set3),
Pf3D7_1246200 (actin I), PF3D7_1218800 (psop17),
PF3D7_1239400, PF3D7_0704100, PF3D7_0417400, and
PF3D7_1321000, for which transcript levels were in-
creased in activated gametocytes as compared to asexual
blood stages, immature gametocytes and non-activated
gametocytes (Figure 2B), indicating that these genes may
play an important role downstream of gametocyte acti-
vation in the mosquito midgut. SET3 was previouslydescribed to accumulate in male gametocytes, where it
contributes to a prompt entry and execution of S/M
phases during microgametogenesis [40]. SET domains are
assigned to chromatin dynamics and are often found in
histone methyltransferases, thus they play a role in the
epigenetic control of gene regulation. The P. falciparum
genome encodes for at least nine SET-domain-containing
proteins which exhibit five different types of substrate
specificities [41].
Actin I was described as part of the plasmodial motor
complex (reviewed in [42]) and was recently also reported
to be present in gametocytes [33,43]. Furthermore,
PSOP17 (putative secreted ookinete protein 17) was previ-
ously reported to be expressed in mature gametocytes of
P. falciparum [9,12] and in ookinetes of P. berghei [44]. In
addition, transcript expression of the two control genes,
PF3D7_1031000 (pfs25) and PF3D7_1412500 (actin II)
was strong in gametocytes compared to asexual blood
stage parasites and increased during gametocyte activation
(Figure 2B).
Eight genes had an increased transcript expression in
gametocytes compared to asexual blood stage parasites,
and transcript levels either remained constant or decreased
following activation. These include PF3D7_0302100 (clk4),
PF3D7_1115200 (set7), PF3D7_0422300 (α-tubulin II),
PF3D7_1103500 (encoding for a CPW-WPC protein),
PF3D7_406200 (pfs16), PF3D7_1457000 (spp), PF3D7_0817600
(encoding for a MAC/PF domain, here termed PPLP6)
and PF3D7_1225600 (Figure 2B). The mRNA splicing
Table 2 Comparison of genes identified by SSH with P. falciparum and P. berghei gametocyte proteome data
Pf P. falciparum GC P. berghei male/female GC Total
PF_ID Gene Ontology MW Troph I & II IV & V V I.II.IV.V FG1 FG 3 FG (1+3) MG1 MG3 MG (1+3) FG +MG FG.MG.PF PB_ID
PF3D7_0210600 signaling 53.7 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_030750
PF3D7_0214600 signaling 204.3 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_031140
PF3D7_0302100 signaling 157.4 2 3 1 7 11 0 0 0 0 0 0 0 11 PBANKA_040110
PF3D7_0303900 signaling 23.2 0 4 4 11 19 0 0 0 0 0 0 0 19 PBANKA_040250
PF3D7_0515300 signaling 255.9 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_111490
PF3D7_0530200 signaling 59.8 0 0 0 3 3 0 0 0 0 0 0 0 3 PBANKA_124460
PF3D7_0624000 signaling 55.3 17 20 2 24 46 6 13 19 11 10 21 40 86 PBANKA_112290
PF3D7_0818200 signaling 30.2 18 21 14 25 60 11 20 31 9 11 20 51 111 PBANKA_071260
PF3D7_0927200 signaling 189.7 0 13 2 5 20 0 0 0 0 0 0 0 20 PBANKA_082800
PF3D7_1004300 signaling 131.7 3 5 1 0 6 0 0 0 0 0 0 0 6 PBANKA_120260
PF3D7_1113100 signaling 25.1 1 2 1 3 6 0 0 0 0 0 0 0 6 PBANKA_093450
PF3D7_1230900 signaling 111.5 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_144560
PF3D7_1233600 signaling 146.3 0 4 0 8 12 0 0 0 0 0 0 0 12 PBANKA_144820
PF3D7_1238100 signaling 266.4 7 9 3 9 21 2 6 8 8 7 15 23 44 PBANKA_145260
PF3D7_1238900 signaling 58.9 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_145340
PF3D7_1356800 signaling 475.7 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_113310
PF3D7_1358600 signaling 118.3 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_113490
PF3D7_1403900 signaling 35.2 6 9 5 12 26 × × × × × × × 26 ×
PF3D7_1433400 signaling 682.5 0 0 2 0 2 0 0 0 0 0 0 0 2 PBANKA_101150
PF3D7_1442200 signaling 118.7 0 0 1 0 1 0 0 0 0 0 0 0 1 PBANKA_130610
PF3D7_1463900 signaling 127.1 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_132710
PF3D7_1464600 signaling 170.5 23 31 0 3 34 0 0 0 0 0 0 0 34 PBANKA_132800
PF3D7_0420300 cell cycle & gene expr. 400.2 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_052170
PF3D7_0513600 cell cycle & gene expr. 129.2 10 29 0 10 39 0 0 0 0 0 0 0 39 PBANKA_111330
PF3D7_0615400 cell cycle & gene expr. 323.2 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_123010
PF3D7_0622900 cell cycle & gene expr. 237.4 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_112180
PF3D7_0811300 cell cycle & gene expr. 200.2 0 2 1 2 5 0 0 0 0 0 0 0 5 PBANKA_142620
PF3D7_0827800 cell cycle & gene expr. 283.6 0 0 1 0 1 0 0 0 0 0 0 0 1 PBANKA_070290
PF3D7_1011800 cell cycle & gene expr. 131.6 41 22 6 17 45 4 11 15 14 0 14 29 74 PBANKA_121020
PF3D7_1018500 cell cycle & gene expr. 12.5 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_050270
PF3D7_1019000 cell cycle & gene expr. 280.8 7 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_050320
PF3D7_1034900 cell cycle & gene expr. 101.2 21 31 0 49 80 6 0 6 3 0 3 9 89 PBANKA_051870
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Table 2 Comparison of genes identified by SSH with P. falciparum and P. berghei gametocyte proteome data (Continued)
PF3D7_1103800 cell cycle & gene expr. 392.0 7 12 0 23 35 0 0 0 0 0 0 0 35 PBANKA_094310
PF3D7_1105500 cell cycle & gene expr. 20.1 1 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_094140
PF3D7_1115200 cell cycle & gene expr. 94.3 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_093250
PF3D7_1347500 cell cycle & gene expr. 42.2 18 15 30 22 67 11 0 11 7 10 17 28 95 PBANKA_136030
PF3D7_1360900 cell cycle & gene expr. 44.8 8 11 11 12 34 × × × × × × × 34 ×
PF3D7_1417200 cell cycle & gene expr. 519.8 5 6 0 6 12 0 0 0 0 0 0 0 12 PBANKA_102550
PF3D7_1445900 cell cycle & gene expr. 60.0 16 25 3 21 49 0 0 0 1 0 1 1 50 PBANKA_130970
PF3D7_1469700 cell cycle & gene expr. 24.6 0 2 0 3 5 0 0 0 0 0 0 0 5 PBANKA_133290
PF3D7_0422300 IMC, cytoskeleton 49.7 11 25 13 30 68 0 0 0 0 0 0 0 68 PBANKA_052270
PF3D7_0503400 IMC, cytoskeleton 13.7 6 5 1 8 14 0 0 0 0 1 1 1 15 PBANKA_110310
PF3D7_0515700 IMC, cytoskeleton 51.8 3 0 0 7 7 1 0 1 0 0 0 1 8 PBANKA_111530
PF3D7_0708000 IMC, cytoskeleton 103.6 0 0 2 12 14 0 0 0 1 0 1 1 15 PBANKA_080520
PF3D7_0724900 IMC, cytoskeleton 222.6 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_062240
PF3D7_0918000 IMC, cytoskeleton 44.6 14 12 1 23 36 0 0 0 0 0 0 0 36 PBANKA_081900
PF3D7_1020200 IMC, cytoskeleton 99.1 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_050430
PF3D7_1246200 IMC, cytoskeleton 41.2 23 28 13 29 70 12 19 31 6 6 12 43 113 PBANKA_145930
PF3D7_1246400 IMC, cytoskeleton 23.5 1 0 0 3 3 0 0 0 0 0 0 0 3 PBANKA_145950
PF3D7_1251200 IMC, cytoskeleton 69.0 1 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_146410
PF3D7_1351700 IMC, cytoskeleton 151.2 0 0 1 0 1 0 0 0 0 0 0 0 1 PBANKA_136440
PF3D7_0102200 proteostasis 126.5 33 3 1 0 4 × × × × × × × 4 ×
PF3D7_0215400 proteostasis 110.8 0 0 1 0 1 0 0 0 0 0 0 0 1 PBANKA_031210
PF3D7_0306200 proteostasis 41.6 4 7 0 8 15 0 0 0 0 0 0 0 15 PBANKA_040460
PF3D7_0708400 proteostasis 86.2 54 60 17 82 159 7 0 7 8 10 18 25 184 PBANKA_080570
PF3D7_0807500 proteostasis 29.5 11 11 2 20 33 3 8 11 4 2 6 17 50 PBANKA_122310
PF3D7_0815800 proteostasis 214.7 0 3 0 0 3 0 0 0 0 0 0 0 3 PBANKA_071500
PF3D7_0818900 proteostasis 73.9 45 46 33 57 136 34 40 74 31 28 59 133 269 PBANKA_071190
PF3D7_0917900 proteostasis 72.4 45 40 42 51 133 24 46 70 16 16 32 102 235 PBANKA_081890
PF3D7_1136400 proteostasis 107.1 0 3 0 11 14 1 0 1 0 0 0 1 15 PBANKA_091220
PF3D7_1466300 proteostasis 132.8 23 26 3 34 63 4 9 13 4 0 4 17 80 PBANKA_132970
mal_mito_2 metabolism general 53.0 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_MIT0002
PF3D7_0104400 metabolism general 62.5 0 1 1 3 5 0 0 0 0 0 0 0 5 PBANKA_020870
PF3D7_0403200 metabolism general 69.4 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_100080
PF3D7_0511800 metabolism general 69.1 36 29 2 40 71 2 0 2 0 0 0 2 73 PBANKA_111140
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Table 2 Comparison of genes identified by SSH with P. falciparum and P. berghei gametocyte proteome data (Continued)
PF3D7_0801900 metabolism general 552.0 0 0 1 0 1 0 0 0 0 0 0 0 1 PBANKA_122830
PF3D7_0806800 metabolism general 123.0 11 9 4 29 42 0 0 0 0 3 3 3 45 PBANKA_122380
PF3D7_0922200 metabolism general 44.8 25 16 0 4 20 1 2 3 0 0 0 3 23 PBANKA_082310
PF3D7_1444800 metabolism general 40.1 21 23 11 35 69 17 23 40 22 22 44 84 153 PBANKA_130860
PF3D7_0102500 cell surface & PVM 181.2 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_133270
PF3D7_0202500 cell surface & PVM 11.5 1 0 0 0 0 × × × × × × × 0 ×
PF3D7_0406200 cell surface & PVM 16.7 3 9 34 17 60 × × × × × × × 60 ×
PF3D7_0423700 cell surface & PVM 10.2 0 5 0 2 7 × × × × × × × 7 ×
PF3D7_0707300 cell surface & PVM 103.6 3 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_080450
PF3D7_0731500 cell surface & PVM 174.6 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_133270
PF3D7_0930300 cell surface & PVM 195.7 77 0 3 0 3 0 0 0 0 0 0 0 3 PBANKA_083100
PF3D7_1021900 cell surface & PVM 267.4 11 26 4 31 61 0 0 0 0 0 0 0 61 PBANKA_112590/ PBANKA_141230
PF3D7_1028700 cell surface & PVM 58.1 0 0 1 11 12 0 0 0 0 0 0 0 12 PBANKA_051280
PF3D7_1033200 cell surface & PVM 38.9 11 16 0 4 20 × × × × × × × 20 ×
PF3D7_1035300 cell surface & PVM 141.1 0 0 1 0 1 × × × × × × × 1 ×
PF3D7_1035700 cell surface & PVM 80.3 10 0 0 0 0 × × × × × × × 0 ×
PF3D7_1103500 cell surface & PVM 67.3 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_094340
PF3D7_1218800 cell surface & PVM 39.6 0 0 2 5 7 0 0 0 0 0 0 0 7 PBANKA_143440
PF3D7_1228600 cell surface & PVM 86.6 23 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_144330
PF3D7_1335300 cell surface & PVM 382.9 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_000220 + 10 more
PF3D7_0206200 others 62.7 0 0 0 2 2 0 0 0 0 0 0 0 2 PBANKA_030390
PF3D7_0207700 others 108.7 11 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_030480
PF3D7_0311600 others 84.0 0 0 0 5 5 0 0 0 0 0 0 0 5 PBANKA_040960
PF3D7_0320700 others 21.0 0 0 0 8 8 0 0 0 0 0 0 0 8 PBANKA_121780
PF3D7_0403800 others 83.4 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_100150
PF3D7_0709900 others 274.0 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_122050
PF3D7_0817600 others 112.2 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_071320
PF3D7_0930000 others 66.8 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_083070
PF3D7_1027800 others 44.2 17 9 14 18 41 0 0 0 0 0 0 0 41 PBANKA_051190
PF3D7_1033800 others 52.3 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_051760
PF3D7_1103100 others 13.0 2 2 5 4 11 1 0 1 0 0 0 1 12 PBANKA_094360
PF3D7_1207700 others 43.4 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_060620
PF3D7_1358800 others 17.3 8 6 4 9 19 8 5 13 1 0 1 14 33 PBANKA_113510
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Table 2 Comparison of genes identified by SSH with P. falciparum and P. berghei gametocyte proteome data (Continued)
PF3D7_1408600 others 25.1 8 8 7 12 27 2 5 7 2 0 2 9 36 PBANKA_103390
PF3D7_1457000 others 47.6 0 0 0 0 0 2 0 2 0 1 1 3 3 PBANKA_132070
PF3D7_0202400 unknown 141.9 27 0 0 0 0 × × × × × × × 0 ×
PF3D7_0411000 unknown 179.7 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_061240
PF3D7_0417400 unknown 822.4 0 0 1 0 1 0 0 0 0 0 0 0 1 PBANKA_071950
PF3D7_0508900 unknown 370.2 0 2 0 0 2 0 0 0 0 0 0 0 2 PBANKA_110850
PF3D7_0601900 unknown 14.7 0 0 0 1 1 × × × × × × × 1 ×
PF3D7_0704100 unknown 425.3 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_080180
PF3D7_0730800.1 unknown 32.1 5 0 0 0 0 × × × × × × × 0 ×
PF3D7_0904200 unknown 34.0 0 1 0 0 1 0 0 0 0 0 0 0 1 PBANKA_041720
PF3D7_1021700 unknown 830.2 0 0 0 1 1 1 0 1 0 0 0 1 2 PBANKA_050590
PF3D7_1023000 unknown 48.9 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_050720
PF3D7_1024800 unknown 171.1 4 33 15 33 81 0 0 0 0 0 0 0 81 PBANKA_050900
PF3D7_1026100 unknown 23.9 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_051030
PF3D7_1026600 unknown 196.5 0 0 0 0 0 × × × × × × × 0 ×
PF3D7_1114600 unknown 39.6 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_093310
PF3D7_1124200 unknown 49.3 0 0 0 7 7 0 0 0 1 0 1 1 8 PBANKA_092410
PF3D7_1126700 unknown 110.1 0 1 0 0 1 0 0 0 0 0 0 0 1 PBANKA_092170
PF3D7_1225600 unknown 93.1 0 1 0 0 1 0 0 0 0 0 0 0 1 PBANKA_144050
PF3D7_1230100 unknown 61.5 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_144480
PF3D7_1239400 unknown 22.0 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_145390
PF3D7_1316700 unknown 73.4 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_141520
PF3D7_1321000 unknown 80.6 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_141930
PF3D7_1362600 unknown 32.1 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_113860
PF3D7_1438800 unknown 84.0 0 0 0 2 2 0 0 0 0 0 0 0 2 PBANKA_130270
PF3D7_1439600 unknown 22.6 0 6 0 10 16 1 0 1 0 0 0 1 17 PBANKA_130350
PF3D7_1451200 unknown 176.2 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_131490
PF3D7_1452400 unknown 107.5 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_131610
PF troph, peptide hits for gametocyte-less P. falciparum trophozoites [12,13]; I & II, stage I & II P. berghei gametocyte [12,13]; V, stage V P. falciparum gametocytes [9]; I.II.IV.V, sum of all P. falciparum gametocyte data;
FG1, peptide hits from highly purified female P. berghei gametocyte sample 1 [22]; FG3, peptide hits from highly purified female P. berghei gametocytes sample 3 [22]; FG(1+3), sum of both; MG1, peptide hits from
highly purified male P. berghei gametocyte sample 1 [22]; MG3, peptide hits from highly purified male P. berghei gametocyte sample 3 [22]; MG(1+3), sum of both; FG+MG, total number peptide hits from all four P.
berghei gametocyte samples; total FG.MG.PF, total number of P. falciparum & P. berghei gametocyte peptide hits.
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Table 3 Genes identified by SSH with P. berghei orthologs showing destabilization in the absence of DOZI and CITH
P. falciparum
gene ID
P Protein Predicted feature MW P. berghei ortholog
gene ID
DOZI CITH
PF3D7_1011800 74 QF122 antigen KH domain type 1, RNA binding 131.6 PBANKA_121020 1.4 1.1
PF3D7_0724900 0 kinesin-like protein 222.6 PBANKA_062240 2.4 1.2
PF3D7_1033800 0 plasmepsin VII SP, 1 TM, aspartyl protease 52.3 PBANKA_051760 2.1 1.3
PF3D7_1316700 0 conserved Plasmodium protein SP 73.4 PBANKA_141520 2.1 1.4
PF3D7_1321000 0 conserved Plasmodium protein 80.6 PBANKA_141930 1.8 1.6
PF3D7_0303900 19 conserved Plasmodium protein SP, phosphatidyl-ethanolamine-binding
protein PEBP domain
23.2 PBANKA_040250 2.2 1.8
PF3D7_1103500 0 CPW-WPC family protein SP, CPW-WPC domain 67.3 PBANKA_094340 1.3 2.3
PF3D7_1115200 0 SET domain protein, SET7 Chromatin regulator 94.3 PBANKA_093250 2.5 2.3
PF3D7_1207700 0 blood stage antigen 41–3 precursor SP 43.4 PBANKA_060620 2.5 2.8
PF3D7_0904200 1 conserved Plasmodium protein SP, 1 TM 34 PBANKA_041720 1.9 3.2
PF3D7_1362600 0 conserved Plasmodium protein Interacts with splicing factor
3B subunit 2
32.1 PBANKA_113860 3.4 3.5
P, total number of peptides identified in P. falciparum and P. berghei gametocytes [9,12,13,22]; DOZI and CITH, log2 values of transcript abundance WT compared
to DOZI-KO, or WT compared to CITH KO [20].
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asexual blood stages and gametocytes of P. falciparum
[45,46] and a gene knock-out of the orthologous protein
in P. berghei failed to exflagellate upon gametocyte activa-
tion [47]. The gene set7 encodes for one of the nine SET-
domain-containing proteins (see above). Transcript of set7
is destabilized in the absence of DOZI and CITH (compare
with Table 1), pointing at a translational repression of set7
in gametocytes and a role in epigenetic control mechanisms
of the ookinete.
Pfs16 is a transmembrane protein of the gametocyte
PVM [12,27,48,49]. After the PVM has ruptured during
the egress of the activated gametocyte from the host cell,
Pfs16 is not detectable any longer in the sexual stage
parasites [7] (see below), explaining the decrease of
transcript following activation. Furthermore, α-tubulin II
represents a tubulin isoform that is expressed in asexual
blood stage parasites, in gametocytes and in micro-
gametes [50-52]. Targeted gene modification studies in
P. berghei indicated that α-tubulin II plays an import-
ant role for microgametogenesis [53]. The fact that
α-tubulin II transcript levels decrease during gameto-
genesis lets us conclude that the α-tubulin II fila-
ments needed for the formation of the microgametes
are already present in the mature gametocytes prior
to activation.
The presenilin-like signal peptide peptidase (SPP) was
previously reported to be involved in merozoite invasion
and cleavage of the erythrocyte cytoskeletal protein band
3 [54]. A recent study, however, disagreed with these
findings, and reported that SPP is an ER-resident pro-
tease required for growth of the erythrocytic stages [55].
SPP is considered a potential drug target of liver andblood stage parasites [55-57]. The combined data
indicate that SPP is present in the liver, blood and
gametocyte stages, pointing to a role of SPP in multiple
life-cycle stages of Plasmodium.
The gene product of PF3D7_0817600 comprises a
MAC/PF domain, similar to the MAC/PF domains of
the previously described plasmodial perforin-like pro-
teins PPLP1-5 [58] (reviewed in [8]). We therefore
termed the protein PPLP6 in this study. Furthermore,
the gene product of PF3D7_1103500 is a member of a
family of nine secreted proteins with cysteine-rich CPW-
WPC domains [59] (reviewed in [60]). The CPW-WPC
domain is a conserved domain of about 61 residues in
length that exhibits six well-conserved cysteine residues
and six well-conserved aromatic sites. The functions and
life cycle expression patterns of the plasmodial CPW-
WPC proteins are hitherto not known.
Three genes were predominantly expressed in the asexual
blood stages and show a resurgence in transcript expression
in gametocytes during maturation, i.e. PF3D7_1238900
(pk2), PF3D7_1136400 (encoding for a tetratrico peptide
repeat region; TPR), and PF3D7_1021700. The calcium/cal-
modulin-dependent protein kinase PK2 was hitherto only
investigated in the asexual blood stages of P. falciparum
[61,62] and protein expression in gametocytes has not yet
been investigated. The gene product of PF3D7_1136400
comprises a TPR domain, which is known to mediate
protein-protein interactions and the assembly of multi-
protein complexes (reviewed in [63]), but the function of
the plasmodial TPR domain protein is not yet known.
While transcript levels of PF3D7_1136400 increase during
gametocyte development, a drop following activation was
observed.
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Figure 2 (See legend on next page.)
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Figure 2 Changes in transcript expression levels during the formation and activation of P. falciparum gametocytes. (A) Diagnostic
RT-PCR demonstrated the presence of stage-specific transcript in the asexual blood stages of the gametocyte-less strain F12 (F12 ABS) as well as
in immature (stage III/IV) and mature (stage V) non-activated gametocytes (GC) and in gametocytes at 30 min p.a. in vitro. ama-1, marker for ABS;
pfccp2, marker for GC. Transcript of gene hdac1 was detected in all stages investigated, while no hdac1-specific PCR product was detected in
samples lacking reverse transcriptase (RT). (B) Real-time RT-PCR analysis showed changes of transcript expression of 27 of the SSH-identified
genes between ABS, immature and mature non-activated GCs and in GCs at 30 min p.a. in vitro. Transcript expression levels were calculated by
the 2-ΔCt method; the threshold cycle number (Ct) was normalized with the Ct of the gene encoding for seryl tRNA synthetase as reference.
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PF3D7_080700 (su α6), PF3D7_0807500 (gap50), and
PF3D7_1444800 (encoding for fructose 1,6 bisphosphate
aldolase, FBPA) expression was high in asexual blood
stages and decreased during gametocyte development and
following activation (Figure 2B). SU α6 is a component of
the plasmodial proteasome, a proteolytic complex com-
posed of more than 33 SUs that is responsible for the deg-
radation and recycling of ubiquitinated proteins. As an
external control we thus investigated the transcript levels
of another α-ring component, su α5, and revealed similar
changes in the transcript levels of su α5 in asexual blood
stage parasites and gametocytes before and after activation
(Figure 2B).
The genome of P. falciparum encodes for a variety of
chaperones, including heat shock proteins (HSPs) of the
HSP70, HSP90 and DnaJ/HSP40 families (reviewed in
[64]). HSP70-1 was previously described to be located in
the cytoplasm and nucleus of the parasite blood stages
[65] as well as in the PV, pointing to a role in protein
transport to the erythrocyte [66]. Another proposed
function of HSP70-1 includes the protein trafficking to
the apicoplast [67,68], indicating that the chaperone has
several essential functions and is important for multiple
life-cycle stages. It remains to be elucidated, if other of
the identified HSPs have more specific functions during
parasite transmission from human to mosquito. Inte-
restingly in this context, HSP90 belongs to a family of
evolutionarily conserved chaperones which has been
suggested as a capacitor for morphological evolution
because reduction of its function results in phenotypic
variation in Drosophila [69]. In addition, HSP90 displays
multiple roles in stress adaptation and development,
including spermatogenesis, oogenesis and embryogenesis
in insects [70].
The transmembrane protein GAP50 is part of the IMC
of the parasite invasive stages, including the ookinete
[42,71]. Here, it links myosin with the outer membrane
of the IMC and thus contributes to gliding motility of
the parasite. Recently, GAP50 was also described as a
component of the gametocyte IMC [43,72,73], which
appears to be important for the stability of the crescent-
shaped cell. Noteworthy, transcript of the P. berghei
orthologous protein was shown to co-precipitate withDOZI and CITH (G.R. Mair, unpublished observations),
indicating that gap50 is translationally repressed in
gametocytes. Thus, the release of the translational re-
pression and onset of protein synthesis during gameto-
cyte activation might cause the detected decrease in the
gap50 transcript level.
FBPA is an enzyme of glycolysis, and in Plasmodium is
also reported to be part of the motor complex, here
linking TRAP to actin I [71,74]. Noteworthy in this
context, during gametocytogenesis, malaria parasites
shift from glycolysis towards mitochondrial respiration
[75], which might explain the decrease in FBPA expres-
sion in gametocytes compared to asexual blood stage
parasites.
Transcript expression for five genes, PF3D7_0825800
(vsp9), PF3D7_0215400 (encoding for a WD40 motif ),
PF3D7_1351700 (alv6), PF3D7_1033200 (etramp10.2),
and PF3D7_0207700 (sera4), is negligible in game-
tocytes. The gene PF3D7_0815800 encodes for a homo-
log to the yeast vacuolar sorting protein VSP9 with a
predicted function in protein-protein interactions, while
PF3D7_0215400 encodes for a protein with a WD40
motif. WD-repeat proteins are a large family found in all
eukaryotes, implicated in a variety of functions ranging
from signal transduction and transcription regulation to
cell cycle control and apoptosis. The WD40 motifs act
as a site for protein-protein interaction, and proteins
containing WD40 repeats are known to serve as plat-
forms for the assembly of protein complexes or me-
diators of transient interplay among other proteins
(reviewed in [76]). WD-repeat proteins of P. falciparum
have hitherto been described as receptors for protein
kinase C, and as components of the myosin-driven
motor complex [77,78]. Furthermore, ALV6 is a member
of the alveolin family, which comprises seven proteins in
P. falciparum, associated with the membranous sacs of
the IMC [79]. The fact that ALV6 expression decreases
during gametocytogenesis is fairly surprising, conside-
ring that gametocytes possess an IMC (see above). It has
to be elucidated, if the expression of any other alveolin
is up-regulated in gametocytes.
The early transcribed membrane proteins (ETRAMPs)
are proteins of the plasmodial PVM [80,81]. In P. falcip-
arum the proteins were shown to form complexes with
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date, ETRAMP10.2 transcripts were found in P. falcip-
arum trophozoites and the mixed asexual stages and the
liver stages of P. yoelii [80,81]. Because EXP-1 is also
present in the gametocyte PVM [7], the expression of
some of the ETRAMPs in these stages can be expected.
It thus remains to be elucidated, if the other two SSH-
identified ETRAMPs, ETRAMP2 and ETRAMP4, might
play a specific role for gametocytes. Expression of serine
repeat antigen SERA4 in the asexual blood stages has
previously been described [83]. The SERA family
comprises nine proteins with functions in asexual
blood stage growth and host cell egress (reviewed in
[8,84]).
For selected genes we subsequently investigated the
expression changes on the protein level. Antibodies
against the proteins PK2, CLK-4, actin I and actin II,
GAP50, proteasome SU α5, Pfs16, Pfs25 and PPLP6
were used to immunolabel the respective proteins in
samples of P. falciparum F12 asexual blood stages, non-
activated NF54 gametocytes and gametocytes at 30 min
p.a. via indirect immunofluorescence assay (Figure 3A).
Asexual blood stage parasites were highlighted by MSP-
1 labeling; gametocytes were highlighted by labeling of
Pfs25 or Pfs230, respectively. The abundance of the
respective proteins in gametocytes before and after acti-
vation was quantified by measuring the average fluores-
cence signal intensity of a total number of 20 plotted
cells per setting (Figure 3B). A significant up-regulation
in the expression of PK2, actin II and Pfs25 following
gametocyte activation was confirmed (Figure 3A, B).
While PK2 is also expressed in asexual blood stage para-
sites, actin II and Pfs25 cannot be detected in these
stages. On the other hand, CLK4, proteasome SU α5,
and PPLP6 were detected in asexual blood stage
parasites and gametocytes during maturation, but the
proteins were down-regulated in gametocytes at 30 min
p.a. (Figure 3B). While labeling of CLK4 and SU α5
revealed a homogenous expression of these proteins in the
parasite cytoplasm and nucleus, PPLP6-labeling exhibited
a punctuated expression (Figure 3A). Noteworthy, the
PPLP6 labeling disappeared after the gametes have fully
egressed from the enveloping erythrocyte. A role of the
perforin PPLP1 was assigned to rupturing the PVM
during host cell egress by the Apicomplexan parasite
Toxoplasma gondii [85], and a recent study reported the
involvement of PPLP2 in the lysis of the erythrocyte
membrane during the exflagellation of male P. berghei
gametocytes [86]. We thus hypothesize that the plasmo-
dial PPLP6 might also play a role in the rupture of the
enveloping membranes of the activated gametocytes,
explaining its disappearance during gametogenesis. Simi-
larly, the PVM-based protein Pfs16 was not present in
gametocytes at 30 min p.a., since at this time point theparasites have egressed from the enveloping erythrocyte
and the PVM was destroyed [7]. Furthermore, in agree-
ment with the real-time RT-PCR results, actin I is present
in both, asexual blood stages and gametocytes, and a
minor up-regulation in the activated gametocytes was
detected (Figure 3A, B).
Interestingly, we demonstrated a slight up-regulation
in the protein expression of GAP50 at 30 min p.a.,
although a decrease in transcript levels was described
during this process. This phenomenon can be explained
by the fact that translationally repressed gap50 transcript
is present in the non-activated gametocytes (see above),
and that the release of repression during activation leads
to rapid translation and in consequence to a loss in tran-
script abundance and an increase in protein abundance.
It is worth mentioning in this context, that we recently
showed a relocation of GAP50 from the gametocyte
IMC to the plasma membrane during gametogenesis.
Once on the gamete surface, GAP50 binds the human
complement regulator protein factor H from the blood
meal, which enables the extracellular parasite to prevent
lysis by the human complement [43].
In summary we demonstrate that the majority of
genes, which are regulated in their expression levels
during gametocyte activation, have functions assigned to
signaling, cell cycle and gene regulation, and proteo-
stasis, or that they are cytoskeletal or cell surface
proteins. The regulated expression of proteins involved
in signaling and cell cycle control is on the one hand
important for the signaling pathways that result in the
induction of gametogenesis, once temperature drop and
XA are perceived by the parasite [47] (reviewed in [6,87];
on the other hand gametocyte activation releases the
parasites from cell cycle arrest, subsequently leading
to three rounds of rapid DNA replication during micro-
gametogenesis [88].
Furthermore, induction of gametogenesis following
gametocyte activation results on the one hand in the
destruction of the gametocyte IMC and relocation of
cytoskeletal proteins [7,33,34,72,73], on the other hand
in a drastic turn-over of surface proteins (reviewed in
[6]). The molecular changes in the composition of cyto-
skeletal and surface proteins are important for stage
conversion during gametogenesis and for adaptation of
the parasite to the insect host and also promote the
development of the parasite midgut stages, like the
ookinete. The changes in protein expression during
parasite transmission from human to insect further
explain the importance of chaperones and assembly
proteins. The proteasome on the other hand appears to
play only a minor role during gametogenesis. We
hypothesize that proteins which lost their function, once
the parasite has entered the mosquito vector, are only
degraded after the gametes have developed and after
Figure 3 (See legend on next page.)
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Figure 3 Changes in protein expression during formation and activation of P. falciparum gametocytes. (A) Immunofluorescence assays,
using specific antibodies, detected the proteins of interest (in green) in asexual blood stage (ABS) parasites, in gametocytes (GC) and in
gametocytes at 30 min p.a. (aGC). The parasite stages were highlighted with antibodies against stage-specific markers (in red; MSP1 for ABS;
Pfs230 or Pfs25 for GCs and aGCs). Nuclei were highlighted by Hoechst nuclear stain (in blue). Bar, 5 μm. (B) Diagram showing the average signal
intensity of the immunolabeled proteins in gametocytes before and at 30 min p.a. in vitro. Measurements were performed on 20 plotted cells per
setting via quantitative confocal microscopy. Mean ± SD. *p < 0.05;**p < 0.01; ***p < 0.001 (student’s t-test).
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stage conversions has finished.
Noteworthy, the SSH analysis identified a number of
unknown proteins with transmembrane domains and/or
signal peptides, and for six of them, high transcript
levels were shown in mature and activated gametocytes.
For three of the genes, expression in the gametocytes
was higher as compared to asexual blood stage parasites,
and these genes might encode for proteins important for
gametocyte development or gametogenesis.
Conclusions
The here presented data on the changes in the P. falci-
parum transcriptome during gametogenesis provide first
insights into the regulated gene expression occurring
while the malaria parasite passes the initial phase of
transmission to the mosquito. Our findings form the
basis for further studies on genes important for malaria
transmission and support the identification of proteins
involved in the development of the mosquito midgut
stages, which might lead to the discovery of new trans-
mission blocking targets.
Methods
Antibodies
The following antibodies were used in this study: mouse
antisera against Pfs16 and Pfs230 (kindly provided by
Kim Williamson, Loyola University Chicago), pro-
teasome SU α5 [35] and actin II [34], as well as rabbit
antisera against GAP50 (kindly provided by Julian
Rayner, Sanger Institute England; [89]), Pfs230 (against
the immunogenic region C) [90], MSP-1 and Pfs25 (BEI
Resources, Manassas). Mouse antisera against actin I,
PPLP6, PK2, and CLK4 were generated for this study
(see below).
Parasite culture
Gametocyte-less F12 strain and gametocyte-forming
NF54 isolate of P. falciparum were cultivated in vitro in
RPMI 1640 medium complemented with 10% heat-
inactivated human serum as described [91]. As soon as
stage II gametocytes started to emerge in the NF54 cul-
ture, the culture medium was supplemented with 50
mM N-acetyl glucosamine (GlcNac) for approximately 5
days to kill the asexual blood stages [92]. The gameto-
cyte culture was then maintained in normal culturemedium without GlcNac until immature (stage III and
IV) or mature stage V gametocytes were harvested and
enriched by Percoll gradient purification [93]. The ma-
ture stage V gametocytes were divided into two aliquots,
and one aliquot was subsequently incubated in game-
togenesis activating solution (1.67 mg/ml glucose; 8 mg/ml
NaCl; 1 mg/ml Tris–HCl (pH 8.2) [94], containing 100 μM
XA for 30 min at RT.
Construction of a subtracted cDNA library using the SSH
method
Total RNA was isolated from Percoll-enriched stage V
gametocytes before and at 30 min p.a., using Trizol
reagent (Invitrogen, Karlsruhe, Germany). Subsequently,
mRNA was isolated from total RNA using the Oligotex
mRNA Mini Kit (Qiagen, Hilden, Germany) according
to manufacturer’s instructions, and the SSH analysis was
conducted as previously described [21,95] using the PCR-
Select cDNA Subtraction Kit from Clontech (Mountain
View, CA, USA), according to the manufacturer’s pro-
tocol. Briefly, 220 ng of purified mRNA were reverse-
transcribed into cDNA using a cDNA synthesis primer;
subsequently double-stranded cDNA was generated and
digested with RsaI. The double-stranded cDNA from
activated gametocytes was ligated in separate aliquots to
adaptor 1 or adaptor 2R and were denaturated at 98°C for
90 s and then hybridized at 68°C for 8 h with a 30-fold
excess of double-stranded cDNA of non-activated game-
tocytes. Subsequently, both samples were mixed together
with a 10-fold excess of freshly denatured double-stranded
cDNA from non-activated gametocytes and hybridized at
68°C for 16 h. The sample was then subjected to two
rounds of suppression PCR with PCR-primer 1 and nested
primers supplied with the kit. PCR amplifications were
performed in a total volume of 25 μl using a PCR cycler
(Biometra, Göttingen, Germany) with a heated lid and
the 50Prime PCR Extender System (50Prime, Hamburg,
Germany). An initial adapter extension at 75°C for 5 min
was followed by a denaturation step at 93°C for 30 s and
by 27 cycles of denaturation at 93°C for 15 s, annealing at
66°C for 30 s, and extension at 72°C for 90 s. A final
7-min 72°C step was added to allow complete extension
of the products. The secondary PCR was performed with
nested primer 1 and 2R on 1 μl of the primary PCR pro-
ducts for 15 cycles with an initial denaturation step at
93°C for 1 min, followed by denaturation at 93°C for 15 s,
Ngwa et al. BMC Genomics 2013, 14:256 Page 18 of 21
http://www.biomedcentral.com/1471-2164/14/256annealing at 68°C for 30 s and extension at 72°C for 90 s,
plus a final extension step at 72°C for 7 min. Resulting
PCR products of the secondary subtractive PCR were
purified using the NucleoSpin Extract II kit (Macherey
Nagel, Düren, Germany), ligated into the pGEM-T easy
vector (Promega, Mannheim, Germany) and transformed
into NEB 5-alpha competent E. coli (New England
BioLabs, Frankfurt, Germany). The library was plated on
2×YT agar plates containing 100 μg/ml ampicillin and
incubated at 37°C for 16 h.
Colony PCR, sequencing and computer analysis of cDNA
sequence data
A preliminary colony PCR screen on 20 colonies was
performed with vector-specific primers, i.e. T7-promotor:
50- TAATACGACTCACTATAGGG-30 and SP6: 50-ATTTA
GGTGACACTATAG- 30 (purchased from Thermo elec-
tron, Waltham, MA, USA), using the following conditions:
denaturation at 95°C for 5 min followed by 30 cycles of
denaturation at 95°C for 15 s, annealing at 43°C for 20 s,
and extension at 72°C for 60 s. A final 7-min 72°C step
was added to allow complete extension of the products.
The colony PCR showed that 75% of clones contained an
insert in the vector. Subsequently, 288 randomly picked
clones were screened for the presence of the vector.
Plasmid isolation of 141 positively screened colonies was
performed with the Fast Plasmid Mini kit (Eppendorf,
Hamburg, Germany) and the inserts were sequenced
(GATC Biotech, Konstanz, Germany; sequences listed in
the Additional file 1: Table S1). Sequences were used to
identify similar sequences of the National Center for
Biotechnology Information databases using BLASTX
program (BLASTX 2.2.13; http://www.ncbi.nlm.nih.gov/
BLAST/) and to predict signal sequences, transmembrane
regions and features, using the PlasmoDB program (www.
plasmodb.org) [96].
RNA isolation and real-time RT-PCR
Total RNA was isolated from the mixed asexual F12
cultures, enriched immature NF54 gametocytes (stage III
and IV), non- activated mature gametocytes and gameto-
cytes at 30 min p.a. using the Trizol reagent (Invitrogen)
according to the manufacturer’s protocol. RNA prepa-
rations were treated with RNAse-free DNAse I (Qiagen)
to remove gDNA contamination, followed by phenol/
chloroform extraction and ethanol precipitation. All RNA
samples had A260/A280 ratios higher than 2.1. Two μg of
each total RNA sample were used for cDNA synthesis
using the SuperScript III First-Strand Synthesis System
(Invitrogen), following the manufacturer’s instructions.
Controls without reverse transcriptase were used to investi-
gate potential gDNA contamination by diagnostic PCR
using hdac1-specific primers. RNA quality was further veri-
fied for contamination by monitoring transcripts of stage-specific genes, i.e. ama1 and pfccp2, by diagnostic RT-PCR
(for primer sequences, see Additional file 2: Table S2).
Primers for real-time RT-PCR were designed using the
Primer 3 software (http://frodo.wi.mit.edu/primer3/) and
were initially tested on gDNA in conventional PCR with
the same conditions subsequently used for real-time
RT-PCR (for primer sequences, see Additional file 2:
Table S2). Primers for the reference gene encoding for
seryl tRNA synthetase were obtained from [38]. The
PCR products were subsequently separated by agarose
gel electrophoresis. Primers with high specificity were
further validated by testing amplification efficiency on
10-fold dilutions of gDNA using real-time RT-PCR
followed by melt curve analysis. Primers with low speci-
ficity, efficiency and poor melt curves were redesigned.
Real-time RT-PCR measurements were performed
using the Bio-Rad CFX96 Real-Time Detection System.
Reactions were prepared in triplicate in a total volume of
20 μl using the maxima SyBR green qPCR master mix
(Thermo Scientific, Bonn, Germany) with 20 ng of cDNA
and primer concentrations of 0.3 μM. The following PCR
cycling conditions were used: an initial denaturation step
at 95°C for 10 min, followed by 40 cycles of denaturation
at 95°C for 15 s and annealing/extension at 60°C for 60 s,
followed by a final extension at 95°C for 10 s and a final
melt-curve analysis of 55-95°C. Controls without template
and without reverse transcriptase were included in all
real-time RT-PCR experiments. Transcript expression
levels were calculated by the 2-ΔCt method [36,37], using
the endogenous control gene encoding for P. falciparum
seryl tRNA synthetase (PF3D7_0717700) as reference
[38,39]. Control samples lacking reverse transcriptase
during cDNA synthesis were routinely included dur-
ing each run and exhibited an average threshold cycle
number of 39.Recombinant protein expression and production of
mouse antisera
Recombinant proteins for CLK4, PK2, and actin I were
expressed as fusion proteins with a GST-tag using the
pGEX 4 T-1 vector (Amersham Biosciences, Freiburg,
Germany), PPLP6 recombinant proteins were expressed
as maltose binding protein-tagged fusion proteins using
vector pIH902 (kindly provided by K. Williamson,
Chicago; [90]). DNA was amplified by PCR using gene-
specific primers (for primer sequences, see Additional
file 2: Table S2). Recombinant proteins were expressed
in BL21 (DE3) RIL cells according to the manufacturer’s
protocol (Invitrogen). Recombinant proteins were isolated
as either inclusion bodies (PK2, actin I) as described [16]
or affinity-purified (CLK4 and PPLP6) using glutathione
sepharose (GE Healthcare, Munich, Germany) and amy-
lose resin (New England Biolabs), respectively, according
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were generated by immunizing 6-week-old female NMRI
mice (Charles River Laboratories, Sulzfeld) with 100 μg
recombinant protein emulsified in Freund’s incomplete
adjuvant (Sigma-Aldrich), followed by a boost after 4
weeks. Sera were collected 10 days after the boost. The
housing and handling of the animals followed the guide-
lines of the animal welfare committee of Lower Franconia.Indirect immunofluorescence assay and signal strength
quantification
Asexual F12 blood stage parasites, non-activated NF54
gametocytes and gametocytes at 30 min p.a. were air dried
on glass slides and fixed for 10 min in −80°C methanol.
For membrane permeabilization and blocking of non-
specific binding, fixed cells were incubated for 30 min in
0.01% saponin/0.5% BSA/PBS and 1% neutral goat serum
(Sigma-Aldrich) in PBS. Preparations were then succes-
sively incubated for 1.5 h each at 37°C with the primary
antibody diluted in 0.01% saponin/0.5% BSA/PBS. Binding
of primary antibody was visualized using fluorescence-
conjugated goat anti-mouse or anti-rabbit secondary anti-
bodies (Alexa Fluor 488 or Fluor 596; Molecular Probes,
Karlsruhe, Germany) diluted in 0.01% saponin/0.5% BSA/
PBS. Nuclei were highlighted by incubating the specimens
with Hoechst nuclear stain 33342 (Molecular Probes) for
1 min. Cells were mounted with anti-fading solution AF2
(Citifluor Ltd., Leicester, UK) and sealed with nail varnish.
Digital images were taken using a Leica TCS SP5 confocal
laser scanning microscope and processed using Adobe
Photoshop CS software. For quantitative evaluation of the
average signal intensity, digital images of 20 randomly
selected mature and activated gametocytes were taken
using a Zeiss LSM 510 confocal laser scanning microscope
under the same optimal laser scanning microscopy
settings for each antibody. The average fluorescence signal
intensity of each cell, as indicated by a line edging the
respective cell, was measured by LSM 510 image software
and recorded.Additional files
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